TNFSF14 and hepatocellular carcinoma: According to Fig 10A, except for D40LG and TNFSF14, the expression levels of other immune checkpoints were considerably higher in the high-risk group than in the low-risk group, which may present new insights into immune checkpoint therapy of HCC.